Stevanato Group (NYSE:STVN) Releases FY 2026 Earnings Guidance

Stevanato Group (NYSE:STVN) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 0.690-0.730 for the period, compared to the consensus estimate of 0.700. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion.

Stevanato Group Price Performance

STVN stock traded up €0.20 during mid-day trading on Friday, hitting €18.23. The stock had a trading volume of 655,785 shares, compared to its average volume of 670,605. The company has a current ratio of 1.76, a quick ratio of 1.26 and a debt-to-equity ratio of 0.23. Stevanato Group has a 52 week low of €12.89 and a 52 week high of €28.00. The firm has a market capitalization of $5.52 billion, a P/E ratio of 31.43, a P/E/G ratio of 1.70 and a beta of 0.75. The firm has a fifty day simple moving average of €15.16 and a 200 day simple moving average of €18.75.

Stevanato Group (NYSE:STVN) last released its earnings results on Friday, May 8th. The company reported €0.11 EPS for the quarter, missing the consensus estimate of €0.12 by (€0.01). Stevanato Group had a net margin of 11.83% and a return on equity of 10.44%. The firm had revenue of €273.57 million during the quarter. During the same quarter in the prior year, the company posted $0.10 earnings per share. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis. As a group, research analysts forecast that Stevanato Group will post 0.7 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on STVN shares. Weiss Ratings downgraded shares of Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 11th. Wall Street Zen downgraded shares of Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Citigroup reduced their price target on shares of Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a research note on Thursday, March 5th. Jefferies Financial Group set a $17.50 target price on shares of Stevanato Group in a research report on Tuesday, February 10th. Finally, KeyCorp dropped their price target on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a research report on Thursday, March 5th. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Stevanato Group presently has an average rating of “Hold”.

Institutional Trading of Stevanato Group

Hedge funds and other institutional investors have recently bought and sold shares of the business. State of Wyoming increased its stake in Stevanato Group by 39,216.7% during the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock valued at $58,000 after purchasing an additional 2,353 shares in the last quarter. GW&K Investment Management LLC increased its stake in Stevanato Group by 76.2% during the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock valued at $49,000 after purchasing an additional 1,055 shares in the last quarter. Quantbot Technologies LP bought a new stake in Stevanato Group during the 3rd quarter valued at $68,000. Tower Research Capital LLC TRC increased its stake in Stevanato Group by 1,268.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company’s stock valued at $112,000 after purchasing an additional 4,250 shares in the last quarter. Finally, Squarepoint Ops LLC bought a new stake in Stevanato Group during the 3rd quarter valued at $247,000.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.